Tango Therapeutics (TNGX) Earnings Date, Estimates & Call Transcripts $6.90 +0.22 (+3.29%) Closing price 04:00 PM EasternExtended Trading$6.90 0.00 (0.00%) As of 05:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tango Therapeutics Earnings Summary Tango Therapeutics announced Q2 2025 earnings on August 5, 2025, reporting an EPS of -$0.35, which met the consensus estimate of -$0.35. Quarterly revenue was reported to be $3.18 million, below analysts' expectations of $6.41 million. With a trailing EPS of -$1.33, Tango Therapeutics' earnings are expected to decrease next year, from ($1.19) to ($1.38) per share. Upcoming Q3 Earnings DateNov. 5Before Market OpensEstimatedConsensus EPS (Aug. 5) -$0.35 Actual EPS (Aug. 5) -$0.35 Actual Revenue (Aug. 5) $3.18MQ2 2025 Earnings ResourcesQ2 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)TNGX Upcoming EarningsTango Therapeutics' next earnings date is estimated for Wednesday, November 5, 2025, based on past reporting schedules. Powered by Get Tango Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tango Therapeutics and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataTNGX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TNGX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Tango Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.35-$0.29-$0.32Q2 20254-$0.35-$0.29-$0.33Q3 20254-$0.36$0.10-$0.23Q4 20254-$0.39-$0.27-$0.34 FY 2025 15 -$1.45 -$0.75 -$1.22 Q1 20262-$0.39-$0.32-$0.36Q2 20262-$0.40-$0.33-$0.37Q3 20262-$0.38-$0.34-$0.36Q4 20262-$0.37-$0.35-$0.36 Tango Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/5/2025(Estimated)--------8/5/2025Q2 2025-$0.35-$0.35--$0.35$6.41M$3.18M5/12/2025Q1 2025-$0.34-$0.36 -$0.02-$0.36$6.73M$5.39M2/27/2025Q4 2024-$0.32-$0.35 -$0.03-$0.35$7.84M$4.12M8/7/2024--$0.34-$0.24+$0.10-$0.24$7.39M$19.88M5/8/2024Q1 2024-$0.31-$0.35 -$0.04-$0.35$7.13M$6.47M3/18/2024Q4 2023-$0.28-$0.32 -$0.04-$0.32$7.86M$5.43M11/8/2023Q3 2023-$0.34-$0.23+$0.11-$0.23$8.05M$10.73M Tango Therapeutics Earnings - Frequently Asked Questions When is Tango Therapeutics' earnings date? Tango Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 5th, 2025 based off last year's report dates. Learn more on TNGX's earnings history. Did Tango Therapeutics beat their earnings estimates last quarter? In the previous quarter, Tango Therapeutics (NASDAQ:TNGX) reported ($0.35) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.35). Learn more on analysts' earnings estimate vs. TNGX's actual earnings. How much revenue does Tango Therapeutics generate each year? Tango Therapeutics (NASDAQ:TNGX) has a recorded annual revenue of $24.30 million. How much profit does Tango Therapeutics generate each year? Tango Therapeutics (NASDAQ:TNGX) has a recorded net income of -$130.30 million. TNGX has generated -$1.33 earnings per share over the last four quarters. What is Tango Therapeutics' EPS forecast for next year? Tango Therapeutics' earnings are expected to decrease from ($1.19) per share to ($1.38) per share in the next year. More Earnings Resources from MarketBeat Related Companies AMRX Earnings Date XENE Earnings Date CRNX Earnings Date RARE Earnings Date ARWR Earnings Date NAMS Earnings Date IMVT Earnings Date RXRX Earnings Date KNSA Earnings Date OGN Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity This page (NASDAQ:TNGX) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tango Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tango Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access